| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Mar 7, 2025 | Amneal Pharmaceuticals, Inc. | Director | Sell | 20.0 | -80,000 | -31.90% | ✗ | $712K |
| Jun 29, 2024 | Jul 1, 2024 | Alkermes plc. | Director | Sell | 26.3 | -1,465 | -5.09% | ✗ | $35.3K |
| Jun 9, 2024 | Jun 10, 2024 | Alkermes plc. | Director | Sell | 26.3 | -930 | -3.94% | ✗ | $22.2K |
| Jul 7, 2023 | Jul 10, 2023 | Alkermes plc. | Director | Sell | 26.3 | -1,430 | -6.76% | ✗ | $42.7K |
| Jun 9, 2023 | Jun 12, 2023 | Alkermes plc. | Director | Sell | 26.3 | -911 | -5.66% | ✗ | $28.4K |
| Jun 14, 2022 | Jun 16, 2022 | Alkermes plc. | Director | Sell | 26.3 | -905 | -6.85% | ✗ | $24.6K |
| Jun 9, 2022 | Jun 10, 2022 | Alkermes plc. | Director | Sell | 27.5 | -347 | -4.27% | ✗ | $9.8K |
| Aug 23, 2021 | Aug 24, 2021 | Alkermes plc. | Director | Buy | 91.3 | +1,650 | 100.00% | ✗ | $49.9K |